These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 8041130

  • 1. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J, Geissler EK, Fechner JH, Burlingham WJ, Knechtle SJ.
    J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
    [Abstract] [Full Text] [Related]

  • 2. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF, Tezuka K, Wasfie T, Stegall MD, Reemtsma K, Hardy MA.
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [Abstract] [Full Text] [Related]

  • 3. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.
    Geissler EK, Graeb C, Tange S, Guba M, Jauch KW, Scherer MN.
    Hum Gene Ther; 2000 Feb 10; 11(3):459-69. PubMed ID: 10697120
    [Abstract] [Full Text] [Related]

  • 4. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB, Baldwin WM, Ibrahim S, Sanfilippo F.
    Transplantation; 1995 Jan 27; 59(2):288-93. PubMed ID: 7839453
    [Abstract] [Full Text] [Related]

  • 5. Induction of indirect donor-specific hyporesponsiveness by transportal RT1-peptide pulse in rat skin transplantation.
    Yamamura M, Yagi T, Iwagaki H, Mitsuoka N, Jie L, Sheng SD, Matsuda H, Sadamori H, Inagaki M, Tanaka N.
    Transpl Int; 2003 Aug 27; 16(8):451-5. PubMed ID: 12719799
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF.
    Transplantation; 1998 Oct 27; 66(8):1059-66. PubMed ID: 9808492
    [Abstract] [Full Text] [Related]

  • 7. Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms.
    Knechtle SJ, Wang J, Graeb C, Zhai Y, Hong X, Fechner JH, Geissler EK.
    J Immunol; 1997 Jul 01; 159(1):152-8. PubMed ID: 9200450
    [Abstract] [Full Text] [Related]

  • 8. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y, Goto M, Makino Y, Kikuchi N, Hamaguchi H, Hisama N, Miyanari N, Mori K, Ogawa M.
    J Surg Res; 1996 Feb 15; 61(1):23-9. PubMed ID: 8769937
    [Abstract] [Full Text] [Related]

  • 9. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
    Semiletova NV, Shen XD, Feldman DM, Busuttil RW, Kupiec-Weglinski JW, Ghobrial RM.
    Transplant Proc; 2005 May 15; 37(4):1937-9. PubMed ID: 15919510
    [Abstract] [Full Text] [Related]

  • 10. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M, Yamaguchi Y, Matsuno K, Takata N, Makino Y, Kikuchi N, Hamaguchi H, Hisama N, Miyanari N, Mori K, Ogawa M.
    J Surg Res; 1996 Jan 15; 60(1):216-23. PubMed ID: 8592417
    [Abstract] [Full Text] [Related]

  • 11. In vitro correlates of rejection. II. Rat mixed lymphocyte reactivity in vitro and cardiac allograft acute rejection, hyperacute or accelerated rejection, and prolongation by active immunization.
    Guttmann RD.
    Transplantation; 1977 Feb 15; 23(2):153-7. PubMed ID: 138229
    [Abstract] [Full Text] [Related]

  • 12. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T, Reed E, Suciu-Foca N, Hardy MA.
    Surgery; 1990 Aug 15; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [Abstract] [Full Text] [Related]

  • 13. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A, Saini D, Benshoff N, Goodman J, Desai NM, Chapman WC, Mohanakumar T.
    Transplantation; 2007 Nov 27; 84(10):1316-23. PubMed ID: 18049117
    [Abstract] [Full Text] [Related]

  • 14. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z, Jakobs FM, Pfaff-Amesse T, Sanfilippo F, Baldwin WM.
    J Heart Lung Transplant; 1998 May 27; 17(5):470-8. PubMed ID: 9628565
    [Abstract] [Full Text] [Related]

  • 15. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.
    Geissler EK, Wang J, Fechner JH, Burlingham WJ, Knechtle SJ.
    J Immunol; 1994 Jan 15; 152(2):413-21. PubMed ID: 8283029
    [Abstract] [Full Text] [Related]

  • 16. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD.
    Transplantation; 1997 Nov 27; 64(10):1407-14. PubMed ID: 9392303
    [Abstract] [Full Text] [Related]

  • 17. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y, Miyanari N, Ichiguchi O, Akizuki E, Matsumura F, Matsuda T, Okabe K, Liang J, Ohshiro H, Mori K, Ogawa M.
    Hepatology; 1998 Aug 27; 28(2):450-8. PubMed ID: 9696011
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric analysis of chimerism in the rat tolerant to a renal allograft.
    Naar JD, Fisher RA, Saggi BH, Wakely PE, Tawes JW, Posner MP.
    J Surg Res; 1998 Jul 01; 77(2):179-86. PubMed ID: 9733606
    [Abstract] [Full Text] [Related]

  • 19. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW.
    J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539
    [Abstract] [Full Text] [Related]

  • 20. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS, Wong AV, Soukiasian H, Gallagher S, De Robertis M, Trento A.
    Transplant Proc; 2011 Dec 01; 43(10):3863-8. PubMed ID: 22172861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.